Ionis Pharmaceuticals, Inc. (IONS)
72.34
+1.15
(+1.62%)
USD |
NASDAQ |
Mar 16, 16:00
71.63
-0.71
(-0.98%)
Pre-Market: 08:01
Ionis Pharmaceuticals EPS Diluted (Quarterly) : -1.414 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | -0.3333 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Geron Corp. | -0.0467 |
| MannKind Corp. | -0.0519 |
| Twist Bioscience Corp. | -0.4995 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -229.00M |
| Revenue (Quarterly) | 203.00M |
| Total Expenses (Quarterly) | 432.00M |
| Enterprise Value | 11.89B |
| Gross Profit Margin (Quarterly) | 94.14% |
| Profit Margin (Quarterly) | -112.8% |
| Earnings Yield | -3.41% |
| Normalized Earnings Yield | -3.485 |